HOME >> MEDICINE >> NEWS
Combination of interventions can substantially reduce incidence of malaria in people with HIV

Taking antiretroviral therapy (ART) and the antibiotic co-trimoxazole daily, and using insecticide-treated bed nets could reduce the incidence of malaria by 95% in HIV-infected adults, according to a study in this week's issue of The Lancet.

Malaria and HIV are two of the most common infections in sub-Saharan Africa. Malaria can worsen the clinical outcome for people with HIV, and is more common in HIV- infected adults. ART is linked with HIV virus suppression and decreased mortality in HIV-infected people. Previous studies have shown that preventive treatment with the antibiotic co-trimoxazole can reduce the incidence of malaria in people with HIV, and insecticide-treated bed nets are known to be effective in malaria prevention.

Jonathan Mermin (Centers for Disease Control and Prevention, Entebbe, Uganda) and colleagues assessed the combined effect of ART, co-trimoxazole, and insecticide-treated bed nets on the frequency of clinical malaria in around 1000 people with HIV in Uganda. The investigators introduced the interventions in phases. Phase 1 was no intervention, phase 2 was preventive treatment with co-trimoxazole, phase 3 was co-trimoxazole and ART, and phase 4 was co-trimoxazole, ART, and insecticide-treated bed nets. The researchers found the treatments had a cumulative protective effect on malaria incidence. Compared with no intervention, co-trimoxazole lowered malaria rate by 76%, ART and co-trimoxazole by 92%, and ART, co-trimoxazole, and insecticide-treated bed nets by 95%.

Dr Mermin states: "A combination of co-trimoxazole, antiretroviral therapy, and insecticide-treated bed nets substantially reduced the frequency of malaria in adults with HIV."

"ART probably reduced the frequency of malaria by improving immune function, rather than by direct antimalarial activity," he adds.


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
13-Apr-2006


Page: 1

Related medicine news :

1. Combination treatment stymies breast cancer growth
2. Combination therapy spares some head and neck patients from surgery
3. Combination of personality traits increases risk for heart disease
4. Combination therapy may improve survival for pancreatic cancer
5. Combination therapy with a monocloncal antibody and a vaccine leads to tumor rejection
6. Combination of three new, high-powered MRI systems at PENN is a first in the US
7. Dynamic duo: Combination therapy reverses type 1 diabetes
8. Combination therapy improves AIDS-related lymphoma outcome
9. Combination treatment for brain cancer not detrimental to patients quality of life
10. Combination microbicides protect monkeys against HIV-like virus
11. Combination scanner may increase accuracy in detecting spread, recurrence of head, neck cancer

Post Your Comments:
(Date:6/19/2013)... (PRWEB) June 19, 2013 The ... program is this Friday, June 21 at midnight ... ongoing programs and innovative people who’ve raised the ... information, visit http://www.minonline.com/ima . , Any consumer ... magazine title is eligible to enter. Additionally, advertising ...
(Date:6/19/2013)... Utah (PRWEB) June 19, 2013 Today, ... Wisconsin Health Insurance Exchange . Zane Benefits, which provides ... benefits, is the leader in defined contribution ... to Zane Benefits’ website, as part of the Affordable ... small businesses will become available through new state health ...
(Date:6/19/2013)... The Journal of Parasitology – Although ... software, it creates questions of ethics. For scientific publications, ... already published case shows, scientific publications need clear guidelines ... Journal of Parasitology features a commentary on ... article published in the Journal of the New York ...
(Date:6/19/2013)... Pa. (June 19, 2013) The results of three ... of Neurosurgery , official journal of the ... published by Lippincott Williams & Wilkins , a ... study indicates that continuous "machine learning" using artificial neural ... in patients with advanced brain cancers. Another study in ...
(Date:6/19/2013)... early April, senior leaders from medical, law enforcement, military, ... one question: how can first responders improve survival after ... results of this discussion are now available in " ... ," a concept paper published in the June issue ... Acute Care Surgery , official publication of the ...
Breaking Medicine News(10 mins):Health News:Entry Deadline for min’s Integrated Marketing Awards Is This Friday, June 21 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 3Health News:Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 3Health News:Hartford consensus aims to improve survival after mass shootings 2
(Date:6/19/2013)... SUNNYVALE, Calif. , June 19, 2013 ... today announced that The New England Journal of ... a Phase 1b/2 study evaluating the investigational oral Bruton,s ... chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). ... patients with relapsed/refractory CLL or SLL, even in patients ...
(Date:6/19/2013)... CHICAGO , June 19, 2013 The Physician-Patient ... reduce alarm fatigue. The need to urgently address ... in its Sentinel Event Alert #50 , "Medical device alarm ... Alert database, between January 2008 and June 2012, there were ... 80 resulted in death (82%) , 13 resulted in ...
(Date:6/19/2013)...   Voices Against Brain Cancer (VABC), a ... cancer, today announced that it has awarded Tocagen Inc. ... investigation of Toca 511 & Toca FC in patients ... (Grade 3 or Grade 4).  Tocagen is a privately ... with an initial focus on brain cancer. ...
Breaking Medicine Technology:Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 2Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 4Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 5Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 6Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3
Cached News: